Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
HilleVax
Biotech
Xoma shops for struggling biotechs, buying HilleVax and Lava
Xoma Royalty kicked off the week by buying up a pair of biotechs that have both struggled to recover from recent clinical setbacks.
James Waldron
Aug 4, 2025 9:27am
3 biotechs try to beat the summer heat by shedding staff
Aug 1, 2024 10:49am
HilleVax stock sinks 80% after norovirus vaccine flunks phase 2
Jul 8, 2024 8:55am
Mount Sinai spins out vax venture aimed at infectious diseases
Aug 12, 2022 10:45am
Q2 '22 was weakest quarter for biotech IPOs in more than 5 years
Aug 11, 2022 11:15am
Carlyle's Abingworth buy brings $2 billion for life sciences
Apr 12, 2022 10:00am
